Use of 5α-reductase inhibitors for lower urinary tract symptoms and risk of prostate cancer in Swedish men: nationwide, population based case-control study: Robinson D, Garmo H, Bill-Axelson A, et al (Umeå Univ, Sweden; Uppsala Univ Hosp, Sweden; Uppsala Univ, Sweden; et al) BMJ 346:f3406, 2013§
Publication date: 2014Source: Yearbook of Urology, Volume 2014Author(s): G.L. Andriole
Source: Yearbook of Urology - Category: Urology & Nephrology Source Type: research
More News: Cancer | Cancer & Oncology | Prostate Cancer | Study | Sweden Health | Urology & Nephrology